CardioFocus said three studies that will enroll a total of more than 1,000 participants have been initiated for assessing the performance of its HeartLight endoscopic ablation system in treating patients with atrial fibrillation. The system provides direct visual guidance to enable controlled delivery of laser energy for pulmonary vein isolation with a high procedural flexibility.
3 studies launched to assess CardioFocus' HeartLight ablation system
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.